Hisham et al. synthesized substituted xanthine derivatives as EGFR-targeting anticancer agents and tested their antiproliferative activity against PANC-1, HT29, A549, and MCF-7 cancer cells and MCF-10A normal human breast epithelial cells [60]. Here, EGFR is linked to cancer.